Related Experiment Video
Updated: Jun 23, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Extracorporeal assist circulation for heart failure
Goro Matsumiya1, Shunsuke Saitoh, Yoshiki Sawa
1Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Suita, Japan. matsumg@surg1.med.osaka-u.ac.jp
Abstract:
Acute cardiogenic shock has a high mortality and rescue with mechanical circulatory support remains the only means of survival in most cases. Over the past decade, an increasing number of assist devices have been developed for both temporary and long-term circulatory support. Different types of devices are placed either percutaneously or surgically in different scenarios. Extracorporeal percutaneous devices are useful for rapid implementation of support aimed at stabilizing the patient's general condition by providing enough systemic circulation and improvement of native heart function to allow removal of the device. Instead of veno-arterial bypass, new percutaneous devices that directly drain the left atrium or ventricle seem a promising option. If recovery is unlikely, further assessment and additional treatment should be considered for longer term support aiming at bridging to transplantation or chronic assistance. Short-term support with extracorporeal devices to bridge the patient to long-term therapies is becoming a more and more important strategy. Paracorporeal pulsatile devices still have an important role for patients requiring biventricular support or in the pediatric population. Chronic support aiming at heart transplantation using a paracorporeal device is an alternative option until the new rotary blood pumps become available in Japan.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Cardiomyopathy II: Dilated Cardiomyopathy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Heart Failure II: Pathophysiology
